Monkeypox
📧 Sign up to get email alerts when something new happens for Monkeypox.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-07EMA Authorised: Imvanex (modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus) — Bavarian Nordic A/S
EMA has authorised Imvanex (MVA-BN) vaccine from Bavarian Nordic A/S for smallpox and monkeypox indications.
-
EMA approval · 2026-06-15EMA Authorised: Tecovirimat SIGA (tecovirimat) — SIGA Technologies Netherlands B.V.
The EMA authorized tecovirimat (SIGA) for multiple poxvirus infections, including monkeypox and smallpox, under the marketing authorization …
-
EMA approval · 2025-11-10EMA Authorised: Tecovirimat SIGA (tecovirimat) — SIGA Technologies Netherlands B.V.
The EMA authorised tecovirimat (brand SIGA) for treatment of orthopoxvirus infections including cowpox, monkeypox, vaccinia infection, and s…
-
EMA approval · 2025-10-20EMA Authorised: Imvanex (modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus) — Bavarian Nordic A/S
EMA authorised Imvanex (MVA-BN) from Bavarian Nordic A/S for protection against smallpox and monkeypox, expanding its indications to include…
-
EMA approval · 2022-07-22EMA recommends approval of Imvanex for the prevention of monkeypox disease
EMA recommends approval of Imvanex for preventing monkeypox disease, signaling a new preventive indication for the vaccine.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.